Poly(Limonene Thioether) Scaffold for Tissue Engineering
Name
Poly(limonene thioether).pdf
Size
1.91 MB
Format
Adobe PDF
Checksum (MD5)
e9d5c763d7ede841d626442946dea506
Author(s)
Fischer, Kristin McKeon
Morgan, Kathy Ye
Hearon II, Michael Keith
Sklaviadis, Demetra
Tochka, Zachary L
Anderson, Daniel Griffith
Langer, Robert S
Freed, Lisa E
Fenton, Owen Shea
Date Issued
April 2016
Journal
Advanced Healthcare Materials
Publisher
Wiley Blackwell
Citation
Fischer, Kristin M.; Morgan, Kathy Ye; Hearon, Keith; Sklaviadis, Demetra; Tochka, Zachary L.; Fenton, Owen S.; Anderson, Daniel G.; Langer, Robert and Freed, Lisa E.“Poly(Limonene Thioether) Scaffold for Tissue Engineering.” Advanced Healthcare Materials 5, no. 7 (February 2016): 813–821 © 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Version
Author's final manuscript
Abstract
A photocurable thiol-ene network polymer, poly(limonene thioether) (PLT32o), is synthesized, characterized, fabricated into tissue engineering scaffolds, and demonstrated in vitro and in vivo. Micromolded PLT32o grids exhibit compliant, elastomeric mechanical behavior similar to grids made of poly(glycerol sebacate) (PGS), an established biomaterial. Multilayered PL32o scaffolds with regular, geometrically defined pore architectures support heart cell seeding and culture in a manner similar to multilayered PGS scaffolds. Subcutaneous implantation of multilayered PLT32o scaffolds with cultured heart cells provides long-term 3D structural support and retains the exogenous cells, whereas PGS scaffolds lose both their structural integrity and the exogenous cells over 31 d in vivo. PLT32o membrane implants retain their dry mass, whereas PGS implants lose 70 percent of their dry mass by day 31. Macrophages are initially recruited to PLT32o and PGS membrane implants but are no longer present by day 31. Facile synthesis and processing in combination with the capability to support heart cells in vitro and in vivo suggest that PLT32o can offer advantages for tissue engineering applications where prolonged in vivo maintenance of 3D structural integrity and elastomeric mechanical behavior are required.
MIT Department
Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Harvard University--MIT Division of Health Sciences and Technology
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1002/adhm.201500892
